Potential SP Valuation of AT1 - 80 cents to 1.30/share, page-17

He has been investing in Biotech for quite a few years, so he should know what he is doing...

From the financial review of August 3, 2016;

"A perennial BRW Rich List member, Mr Walker is also a big shareholder in a string of small and micro-cap companies – more than a decade after a move to float his company on the Australian Securities Exchange, which later had a name change, then privatisation, and is now known as Walker Corporation.

Mr Walker's portfolio includes BioTech Capital, which has risen about 34 per cent in the past 12 months and is up 10 per cent since the beginning of 2016."